• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020 December

Post Archive by Month

View Post

Pembrolizumab Slows MSI-H-dMMR Metastatic CRC

In HealthDay News
by Healthday
December 3, 2020

Pembrolizumab superior to chemo for progression-free survival among patients who had not previously received treatment

View Post

Gestational Age at Birth Tied to Hospitalizations to Age 10

In HealthDay News
by Healthday
December 3, 2020

Children born <28 weeks had highest rate of hospital admission; risk also up for children born at 38 weeks

View Post

Dexamethasone May Hinder Immunotherapy for Glioblastoma

In HealthDay News
by Healthday
December 3, 2020

Findings seen in preclinical studies of mice, survival data from patients receiving PD-(L)1 blockade for GBM

View Post

Federal Rules Tied to Reduced ED Visits for Pediatric Magnet Ingestions

In HealthDay News
by Healthday
December 3, 2020

Tighter industry regulation tied to fewer emergency department visits, while lack of rules tied to more visits

View Post

Mental Health Symptoms Common for Perinatal Women During COVID-19

In HealthDay News
by Healthday
December 3, 2020

Women with preexisting mental health diagnoses more likely to have mental health symptoms during pandemic

View Post

Everyone Who Gets COVID-19 Vaccine Will Receive Vaccination Card

In HealthDay News
by Healthday
December 3, 2020

Wallet-sized card will document what dose has been given and when next dose is due

View Post

Menopausal Symptoms Tied to Lower Work Performance

In HealthDay News
by Healthday
December 3, 2020

Women reporting more symptoms also had more chronic diseases, less exercise

View Post

Teens Still Able to Access E-Cigarettes During COVID-19 Pandemic

In HealthDay News
by Healthday
December 3, 2020

Some report changing their point-of-purchase to access products during the pandemic

CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress.

In Dermatology
by ClinOwl
December 3, 2020

Ceramide Kinase-Like Protein (CERKL) was originally described in retinal tissue. CERKL has been shown to protect cells from oxidative stress, and mutations in CERKL underlie the inherited disease, retinitis pigmentosa. …

Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.

In Dermatology
by ClinOwl
December 3, 2020

Melanoma aetiology has been proposed to have two pathways – determined by naevi and type of sun exposure – and related to the anatomical site where melanoma develops.We examined associations …

  • Page 33 of 37
  • ←
  • 1
  • ...
  • 32
  • 33
  • 34
  • ...
  • 37
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

December 2020
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Nov   Jan »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer